Hyperparathyroidism is diagnosed primarily through blood tests that measure calcium and parathyroid hormone (PTH) levels. In the most common form, primary hyperparathyroidism, the hallmark finding is elevated calcium alongside a PTH level that is inappropriately high. But reaching a clear diagnosis often involves more than a single blood draw, especially when results fall in a gray zone or calcium levels look normal despite overactive parathyroid glands.
The Two Key Blood Tests
The diagnostic process starts with two measurements: albumin-adjusted serum calcium and intact PTH. Calcium circulates in your blood partly bound to a protein called albumin, so labs adjust the raw calcium number based on your albumin level to get a more accurate reading. The normal range for this adjusted calcium is roughly 2.2 to 2.6 mmol/L (about 8.8 to 10.4 mg/dL).
If your adjusted calcium comes back at 2.5 mmol/L or above on at least two separate occasions and there’s clinical suspicion of hyperparathyroidism, your doctor will order a PTH test. If calcium is 2.6 mmol/L or above on two occasions, PTH testing is recommended regardless. The critical question isn’t just whether PTH is “high” in an absolute sense. It’s whether PTH is inappropriately elevated for the calcium level. Normally, when calcium rises, your parathyroid glands should dial PTH production down. In primary hyperparathyroidism, PTH stays elevated or sits in the upper half of the normal range even though calcium is already high. That combination is the diagnostic signature.
If PTH falls above the midpoint of the reference range while calcium is elevated, specialist evaluation is warranted. If PTH is genuinely low while calcium is high, the parathyroid glands aren’t the problem, and other causes of high calcium (including cancer) need to be investigated.
Why Ionized Calcium Sometimes Matters More
Standard blood panels measure total calcium, but a portion of that calcium is bound to albumin and isn’t biologically active. Ionized calcium, the “free” form your body actually uses, can sometimes catch cases that total calcium misses. Research has shown that ionized calcium is a more sensitive indicator of primary hyperparathyroidism: there is a significantly greater chance of ionized calcium being elevated without a corresponding rise in total serum calcium than the reverse. Ionized calcium also correlates more closely with parathyroid adenoma size and disease severity.
Your doctor may order ionized calcium when total calcium is borderline, when albumin levels are abnormal (common in liver disease or malnutrition), or when clinical suspicion is high but standard results are inconclusive.
Ruling Out a Genetic Lookalike
Before confirming primary hyperparathyroidism, doctors need to exclude a harmless inherited condition called familial hypocalciuric hypercalcemia (FHH). People with FHH have mildly elevated calcium and normal or slightly high PTH, which looks a lot like hyperparathyroidism on paper. The difference matters enormously because FHH doesn’t require surgery.
The key test is a 24-hour urine collection that measures how much calcium your kidneys excrete. From this, a calcium-to-creatinine clearance ratio is calculated. A very low ratio (below 0.01) points to FHH in 80% to 90% of cases. Values between 0.01 and 0.02 fall in a gray zone where genetic testing may be recommended. A ratio above 0.02 supports a diagnosis of primary hyperparathyroidism. Skipping this step can lead to unnecessary surgery for a condition that needs no treatment.
The Vitamin D Check You Shouldn’t Skip
Vitamin D levels play a surprisingly important role in getting an accurate diagnosis. When vitamin D is low, your body compensates by ramping up PTH production, a condition called secondary hyperparathyroidism. This can mimic or mask primary disease. The Fourth International Workshop on hyperparathyroidism recommended confirming that your 25-hydroxyvitamin D level is above 20 ng/mL before interpreting PTH results. For people without symptoms, a target above 30 ng/mL is suggested.
Vitamin D deficiency is also linked to a more severe presentation of primary hyperparathyroidism when both conditions coexist. If your vitamin D is low, your doctor will typically correct that deficiency first and then recheck PTH and calcium before finalizing a diagnosis.
When Calcium Levels Look Normal
A subset of people have consistently elevated PTH but calcium levels that remain within the normal range. This is called normocalcemic hyperparathyroidism, and it’s increasingly recognized as an early or mild form of the disease. These cases are often discovered when someone is being evaluated for osteoporosis or kidney stones.
Diagnosing normocalcemic hyperparathyroidism requires a methodical approach. Both albumin-adjusted calcium and ionized calcium must be confirmed normal on at least two occasions over six months. All common causes of secondary PTH elevation need to be excluded first: vitamin D deficiency (below 30 ng/mL), kidney impairment (PTH rises when kidney filtration drops below 60 mL/min), calcium-poor diets, and certain medications. Some patients are given a course of supplemental calcium to see if their PTH normalizes, which would suggest the elevated PTH was simply a response to low dietary calcium rather than autonomous gland overactivity. In select cases, screening for celiac disease is also performed, since it can impair calcium absorption.
Distinguishing Primary, Secondary, and Tertiary Forms
The three types of hyperparathyroidism have distinct laboratory profiles. In primary disease, the parathyroid glands overproduce PTH on their own, leading to high calcium and high PTH. In secondary hyperparathyroidism, something else (usually chronic kidney disease) is driving calcium down and phosphate up, and PTH rises as a normal compensatory response. Calcium is typically low or normal, phosphate is high, and PTH is elevated. In tertiary hyperparathyroidism, which develops after prolonged secondary disease, the parathyroid glands become autonomous. At that point, calcium, phosphate, and PTH are all elevated.
Your doctor can usually distinguish between these forms by looking at the pattern of calcium, phosphate, PTH, and kidney function together. The treatment approach is very different for each, so getting the classification right is essential.
Assessing Bone and Kidney Impact
Once hyperparathyroidism is confirmed through blood and urine tests, doctors evaluate what the disease has already done to your bones and kidneys. Excess PTH accelerates bone turnover, thinning the dense outer layer of bone (cortical bone) particularly at the hip and forearm.
A DXA scan, the standard bone density test, should be performed at three specific sites: the lumbar spine, the hip, and the distal forearm. Including the forearm is important because hyperparathyroidism preferentially thins cortical bone, and the forearm is rich in cortical bone. A standard DXA that only checks the spine and hip can underestimate bone loss in this condition. Kidney imaging or a history of kidney stones is also part of the workup, since excess calcium in the urine promotes stone formation.
Imaging to Locate the Problem Gland
Imaging studies are not used to diagnose hyperparathyroidism. They’re ordered after the diagnosis is already established by blood work, specifically to help surgeons plan an operation. The two most common techniques are high-resolution ultrasound of the neck and a sestamibi scan, a nuclear medicine test where a small amount of radioactive tracer is injected and taken up preferentially by overactive parathyroid tissue.
Individually, each scan has a sensitivity of roughly 54% to 57%, meaning they miss the abnormal gland in nearly half of cases when used alone. Specificity, however, is excellent at 98% to 99%: when either test identifies a gland, it’s almost always correct. Combining both raises overall sensitivity to about 78%. When ultrasound and sestamibi agree on the location of a single enlarged gland, surgeons can often use a smaller, targeted neck incision rather than exploring all four parathyroid glands. Additional imaging options include CT, MRI, and PET scans, each with sensitivities in the 50% to 80% range depending on the clinical scenario.
A negative imaging study does not rule out hyperparathyroidism. If blood work clearly confirms the diagnosis, surgery can still proceed with a traditional bilateral neck exploration even when imaging fails to pinpoint the culprit gland.